Epilepsy as a pyridoxine-dependent condition: quantified urinary biomarkers for status evaluation and monitoring antiepileptic treatment.

MLA

Dolina, Svetlana, et al. “Epilepsy as a Pyridoxine-Dependent Condition: Quantified Urinary Biomarkers for Status Evaluation and Monitoring Antiepileptic Treatment.” Medical Hypotheses, vol. 79, no. 2, Aug. 2012, pp. 157–64. EBSCOhost, https://doi.org/10.1016/j.mehy.2012.04.022.

APA

Dolina, S., Margalit, D., Malitsky, S., Pressman, E., & Rabinkov, A. (2012). Epilepsy as a pyridoxine-dependent condition: quantified urinary biomarkers for status evaluation and monitoring antiepileptic treatment. Medical Hypotheses, 79(2), 157–164. https://doi.org/10.1016/j.mehy.2012.04.022

Chicago

Dolina, Svetlana, Dov Margalit, Sergey Malitsky, Eugeny Pressman, and Aharon Rabinkov. 2012. “Epilepsy as a Pyridoxine-Dependent Condition: Quantified Urinary Biomarkers for Status Evaluation and Monitoring Antiepileptic Treatment.” Medical Hypotheses 79 (2): 157–64. doi:10.1016/j.mehy.2012.04.022.